- CA$46.29m
- CA$45.76m
- CA$0.07m
Brief: Diagnos Inc signs one-year screening contract in North Africa
Brief: Diagnos announces DTC eligibility of its common shares in the U.S.
Brief: Diagnos says cardiovascular artery disease prevention score development six to twelve months ahead of schedule
Brief: Diagnos announces restatement of March 31, 2017 financial statements which resulted in a decrease in expenses of $2,491,096
Brief: Diagnos implementation of diagnos Cara Telemedicine Platform
Brief: Diagnos inc announces signature of new $4.16 million contract with Government Of Mexico
Brief: DIAGNOS announces amendment to its stock option plan
Brief: Diagnos announces private placement of up to $3.3 mln
Brief: Diagnos says divesting mining division
Brief: Bayer Canada and Diagnos join efforts against diabetes
Brief: Diagnos Inc says private placement of up to $1 mln units